Imatinib therapy in a patient with suspected chronic neutrophilic leukemia and FIP1L1-PDGFRA rearrangement

Blood

Volumn 122, Issue 19, 2013, Pages 3387-3388

  Jain, Nitin ^a   Khoury, Joseph D ^a   Pemmaraju, Naveen ^a   Kollipara, Praveen ^a   Kantarjian, Hagop ^a   Verstovsek, Srdan ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; FIP1L1-PDGFRA FUSION PROTEIN, HUMAN; IMATINIB; ONCOPROTEIN; PIPERAZINE DERIVATIVE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PYRIMIDINE DERIVATIVE;

CASE REPORT; GENETICS; HUMAN; LEUKEMIA, NEUTROPHILIC, CHRONIC; MALE; MIDDLE AGED; MUTATION; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BENZAMIDES; HUMANS; LEUKEMIA, NEUTROPHILIC, CHRONIC; MALE; MIDDLE AGED; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; MUTATION; ONCOGENE PROTEINS, FUSION; PIPERAZINES; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TREATMENT OUTCOME;

EID: 84891688390     PISSN: None     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-07-516500     Document Type: Article

References (0)